Lamisil

Medicinal product

(Invented) name

Lamisil

Active substance (s)

Terbinafinas

Strength

250 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

D01BA02, Terbinafine

Marketing authorisation holder

SIA Novartis Baltics, Latvija

Date of authorisation

1994-03-31

Date of renewal

2012-04-23

Documents

0101 Lamisil 250mg tab RPP 2024 07 15.docx

0101 Pakuotės lapelis 2024 07 15.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Terbinafinas	250 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
2599	8181	1008181	lizdinė plokštelė	N14		Receptinis	LT/1/94/0101/004	Netiekiama	2025-05-12	-	No	-	-	Download

Stadijos

Data	Stadija
2025-07-30	Išregistruotas
2012-04-23	Perregistruotas
1994-03-31	Registruotas